Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SUMICHEM

SUMICHEM

CommoditiesFertilizers & Agrochemicals₹16632 cr market cap
₹344.15 ▲ +2.96% today As of 19 Nov 2026
52-week low ₹313.9052-week high ₹564.95

-40.8% from the 52-week high · +6.5% above the low

Sumitomo Chemical India Ltd. engages in the manufacture and sale of agricultural and household insecticides and animal nutrition products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,642 full-time employees. The company went IPO on 2020-01-27. The firm manufactures, imports and markets products for crop protection, grain fumigation, rodent control, bio pesticides, environmental health, professional pest control and feed additive. The company is primarily engaged in manufacturing and sales of household insecticides, agricultural pesticides, public health insecticides and animal nutrition products. The company operates two segments, namely Agro Chemicals and Others (environmental health division and animal nutrition division). Its product range comprises of chemistry sourced from its parent company, Sumitomo Chemical Company and biological products sourced from United States-based subsidiary, Valent Biosciences LLC, which is engaged in producing a range of naturally occurring pesticides and plant growth regulators. The company also produces various technical grade pesticides in its manufacturing units with indigenous research and development (R&D) facility.

The short version. SUMICHEM reported revenue of ₹907 crore for Sep 2026, down 2.5% from a year earlier. Net profit was ₹157 crore (down 11.8% year on year). Return on equity was 16.0% in Mar 2026. Promoter holding was 75.0% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

SUMICHEM trades 40.8% below its 52-week high and 6.5% above its 52-week low.

Change over period: —

1M-14.8%
3M-39.7%
6M-27.5%
1Y-26.7%

2 · The business

Is it growing?

Sales, year on year-2.5%

Sep 2026 revenue of ₹907 cr.

Profit, year on year-11.8%

Sep 2026 net profit of ₹157 cr.

Net margin17.3%

1.8 pts lower than a year earlier.

3-year growth2.6% profit

Revenue compounded at -1.6% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue90710636845689301057679642
Net profit1572151117617817810087
Net margin %17.320.216.313.319.116.914.713.5
EPS (₹)3.154.32.231.523.563.572.01.74

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Revenue3238314928443511306526452425
Net profit543505370502424345205
Net margin %16.816.113.014.313.813.18.4
EPS (₹)10.8810.137.410.068.496.924.1

3 · The quality

How well does it turn capital into profit?

Return on equity was 16.0% in Mar 2026; debt to equity is 0.00.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %16.017.415.121.1
Return on capital %21.022.920.227.1
EBITDA margin %23.723.019.420.0
Net margin %16.015.512.614.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR-1.6%4.9%
Profit CAGR2.6%9.5%
Debt to equity0.00
Interest cover94.0x
Current ratio3.44
P/E ratio30.0

4 · The owners

Who holds it, and are they adding?

Promoter holding75.0%

Unchanged over 8 quarters.

Foreign institutions2.89%

Down 0.7 pts over 8 quarters.

Domestic institutions9.69%

Up 2.73 pts over 8 quarters.

Mutual fund schemes89

+24 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter75.075.075.075.075.075.075.075.00.0
FII3.593.633.653.653.373.43.022.89-0.7
DII6.968.148.158.478.658.989.339.69+2.73
Public14.4513.2313.212.8812.9712.6112.6512.42-2.03

Mutual fund holdings · Oct 2026

89 schemes hold this stock

65 the month before.

  • quant Commodities Fund4.1% of NAV
  • quant Manufacturing Fund3.03% of NAV
  • Baroda BNP Paribas Manufacturing Fund1.93% of NAV
  • TATA RESOURCES & ENERGY FUND1.25% of NAV
  • ADITYA BIRLA SUN LIFE BAL BHAVISHYA YOJNA1.21% of NAV
  • The Wealth Company Large & Mid Cap Fund1.18% of NAV
  • Kotak Nifty Chemicals ETF1.17% of NAV
  • Groww Nifty Chemicals ETF1.17% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SUMICHEM are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SUMICHEM

What is the SUMICHEM share price?

SUMICHEM (SUMICHEM) last closed at ₹344.15, up 2.96% on the day. Its 52-week range is ₹313.90 to ₹564.95.

What is the market cap of SUMICHEM?

SUMICHEM has a market capitalisation of about ₹16,632 crore. Its price-to-earnings ratio is 30.0.

How are SUMICHEM's latest results?

SUMICHEM reported revenue of ₹907 crore for Sep 2026, down 2.5% from a year earlier. Net profit was ₹157 crore (down 11.8% year on year). Return on equity was 16.0% in Mar 2026. Promoter holding was 75.0% in Sep 2026, up 0.00 points over 8 quarters.

Who owns SUMICHEM?

As of Sep 2026, shareholding was: Promoter 75.0%, FII 2.89%, DII 9.69%, Public 12.42%.

How many mutual funds hold SUMICHEM?

89 mutual fund schemes held SUMICHEM in October 2026. That compares with 65 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 25 Jul 2025 · Final Dividend - Rs. 1.2
  • 19 Jul 2024 · Final Dividend - Rs. 0.9
  • 14 Feb 2024 · Special Dividend - Rs. 5
  • 21 Jul 2023 · Final Dividend - Rs. 1.2
  • 21 Jul 2022 · Final Dividend - Rs. 1
  • 22 Jul 2021 · Final Dividend - Rs. 0.8

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.